Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Leflunomide and anthralin may effectively treat severe alopecia areata.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Finasteride reduces movement issues in Parkinson's disease rats.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

A 1.0% tyrosine diet increases melanin in chicken feathers.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

SGK3 is essential for proper hair growth and health.

FGF5s can block the effects of FGF5, which may help control hair growth in cashmere goats.

Increasing Wnt5a in mice skin delays hair growth but doesn't stop it.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Gamma-rays exposure during the resting phase of hair growth can damage hair regeneration and color in mice.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Apple extract called procyanidin B-2 was found to greatly increase hair growth.

Targeted cancer therapies often cause serious skin problems that need careful management.